Harvard Gazette article on new research from Bradley Hyman and colleagues, co-first authors Susanne Wegmann and Sarah L. DeVos, applying a genetic engineering strategy to dramatically reduce levels of tau — a key protein that accumulates and becomes tangled in the brain during the development of Alzheimer’s disease — in an animal model of the condition.